基于Ins/PI3K/Akt通路探讨藏药宽筋藤“清除隆热”防治AD的物质基础和作用机制

基本信息
批准号:81660713
项目类别:地区科学基金项目
资助金额:37.00
负责人:黄丽萍
学科分类:
依托单位:江西中医药大学
批准年份:2016
结题年份:2020
起止时间:2017-01-01 - 2020-12-31
项目状态: 已结题
项目参与者:谢一辉,高燕萍,格桑次仁,潘琳娜,于梅,刘文琴,刘超,侯敏,马亚娟
关键词:
Ins/PI3K/Akt通路阿尔茨海默病清除隆热物质基础宽筋藤
结项摘要

Alzheimer’s disease(AD), also known as type 3 diabetes, has become a most challenging health concern on the aging society, and there are no effective methods and drugs on its treatment at present. To improve the insulin pathway sensitivity as targets for effective components, is a new breakthrough on AD treatment. Tibetan medicine has a unique curative effect on AD. Tibetan medicine thinks that much more heat obstructed in Long is the core mechanism on the occuring of diabetes, which damages white vein and can induces dementia. Tibetan medicine Caulis Tinosporae, also named as Le Zhe, can clear Long heat, detoxicate, calm the nerves, and is conventionally used in aging disease and AD. In our previous research, Caulis Tinosporae has good effects on AD model rats, and can reduce insulin resistance of diabetic rats. But the research of Caulis Tinosporae is limited to a small amount of medicinal herbs identification, and the efficacy and material base study of Caulis Tinosporae is still very little. In this study, a “Long heat into the brain” AD model combined disease will be proposed to establish with high sugar and high fat diet + STZ intraperitoneal injection + Aβ25-35 hippocampus injection. The effective parts of Caulis Tinosporae will be determined from efficacy index such as ethology, Aβ and p-Tau deposition, hippocampus morphology. The active ingredients of Caulis Tinosporae will be separated and identificated by using reverse phase chromatography, preparative chromatography, molecular imprinting, fingerprint technology, and combined with the classical AD cell model effects. The molecular mechanisms of Caulis Tinosporae on AD will be focus on the Ins/PI3K/Akt pathway. With the active ingredient group or active ingredients monomer as testing index, the quality standards of Caulis Tinosporae medicinal materials on AD will be established. This study will provide an important experimental evidence for the discovery of AD new drugs research, help to explain the Tibetan medicine connotation of “Long heat into the brain” and Caulis Tinosporae “clearing Long heat” to prevent and treat AD, and lay the foundation for the comprehensive development and utilization of Tibetan medicinal materials of Caulis Tinosporae.

阿尔茨海默病(AD)又称3型糖尿病,现有药物疗效不理想。以提高胰岛素通路敏感性为靶点寻找有效成分,是AD治疗新突破点。藏医认为,糖尿病隆热偏盛,入脑损伤白脉,发为痴呆。宽筋藤又名勒哲,在藏族地区习用于治疗衰老病和AD。本课题组前期实验发现宽筋藤有良好的抗AD作用,且可减轻糖尿病大鼠胰岛素抵抗。目前宽筋藤仅限于少量的药材鉴别研究,药效及物质基础研究甚少。本项目拟采用高糖高脂饮食+STZ+Aβ25-35,建立“隆热入脑”AD病证结合动物模型,综合行为学、Aβ和p-Tau沉积、海马形态学等药效,确定宽筋藤有效部位。采用反相色谱、制备色谱、分子印迹、指纹图谱等技术,结合经典AD细胞模型,分离并明晰宽筋藤活性成分,从Ins/PI3K/Akt通路深入研究其作用机制,建立宽筋藤质量标准。可为藏医“隆热入脑”致AD和宽筋藤“清除隆热”治疗AD提供实验依据,对发现AD新药、促进宽筋藤的综合开发有重要意义。

项目摘要

宽筋藤在藏族地区习用于治疗衰老病和AD,但目前宽筋藤防治AD药理作用机制及物质基础研究甚少。本项目采用高糖高脂饮食+STZ+Aβ25-35,建立“隆热入脑”AD病证结合动物模型,综合行为学、Aβ和p-Tau沉积、海马形态学等药效,明确了宽筋藤有效部位。采用硅校柱、反相色谱、制备色谱等技术,分离得到宽筋藤单体化合物48个,其中新化合物3个;结合经典AD细胞模型,明确宽筋藤活性成分为紫丁香苷、Tinosinenside A等;从Ins/PI3K/Akt通路和NFκB/NLRP3/Caspase1通路深入研究有效部位和有效成分的作用机制;采用HPLC法建立宽筋藤药材指纹图谱。本研究可为藏医“隆热入脑”致AD和宽筋藤“清除隆热”治疗AD提供实验依据,对发现AD新药、促进宽筋藤的综合开发有重要意义。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

DOI:10.1080/15287394.2018.1502561
发表时间:2018
2

氟化铵对CoMoS /ZrO_2催化4-甲基酚加氢脱氧性能的影响

氟化铵对CoMoS /ZrO_2催化4-甲基酚加氢脱氧性能的影响

DOI:10.16606/j.cnki.issn0253-4320.2022.10.026
发表时间:2022
3

伴有轻度认知障碍的帕金森病~(18)F-FDG PET的统计参数图分析

伴有轻度认知障碍的帕金森病~(18)F-FDG PET的统计参数图分析

DOI:10.3760/cma.j.issn.0376-2491.2018.33.004
发表时间:2018
4

针灸治疗胃食管反流病的研究进展

针灸治疗胃食管反流病的研究进展

DOI:
发表时间:2022
5

天津市农民工职业性肌肉骨骼疾患的患病及影响因素分析

天津市农民工职业性肌肉骨骼疾患的患病及影响因素分析

DOI:
发表时间:2019

黄丽萍的其他基金

批准号:21377019
批准年份:2013
资助金额:80.00
项目类别:面上项目
批准号:31901202
批准年份:2019
资助金额:24.00
项目类别:青年科学基金项目
批准号:51578104
批准年份:2015
资助金额:63.00
项目类别:面上项目
批准号:21777017
批准年份:2017
资助金额:65.00
项目类别:面上项目
批准号:30860350
批准年份:2008
资助金额:25.00
项目类别:地区科学基金项目
批准号:51178077
批准年份:2011
资助金额:64.00
项目类别:面上项目
批准号:21077017
批准年份:2010
资助金额:36.00
项目类别:面上项目

相似国自然基金

1

基于淫羊藿苷调控INS/PI3K/AKT通路抗阿尔茨海默病的作用机制研究

批准号:81660599
批准年份:2016
负责人:金凤
学科分类:H3501
资助金额:40.00
项目类别:地区科学基金项目
2

基于PI3K/AKT/mTOR通路白头翁皂苷抗肿瘤物质基础和作用机制研究

批准号:81573548
批准年份:2015
负责人:杨世林
学科分类:H3203
资助金额:63.00
项目类别:面上项目
3

基于PI3K/AKT/DNMT1信号通路调控BACE1蛋白表达探讨化痰开窍法改善AD认知功能的作用机制

批准号:81904112
批准年份:2019
负责人:杨卉
学科分类:H3108
资助金额:20.00
项目类别:青年科学基金项目
4

基于PI3K/AKT/GSK-3β信号通路调控HOC上皮间质转化探讨鳖甲煎丸防治肝癌前病变的作用机制

批准号:81774037
批准年份:2017
负责人:贺松其
学科分类:H3302
资助金额:50.00
项目类别:面上项目